N‐Methyl‐3,4‐methylendioxymethamphetamine (MDMA)‐related coagulopathy and rhabdomyolysis: A case series and literature review
Abstract Coagulation changes, thrombosis, and hemorrhage have been described in patients following N‐methyl‐3,4‐methylenedioxymethylamphetamine (MDMA) intoxication who subsequently developed serotonin syndrome and rhabdomyolysis. The clinical features and mechanism of this remain poorly described. W...
Main Authors: | Andrew J. Doyle, Joel Meyer, Karen Breen, Beverley J. Hunt |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-07-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12360 |
Similar Items
-
Serotonin Syndrome with Rhabdomyolysis: A Case Report and Recommended Prevention
by: Weerasak Muangpaisan, et al.
Published: (2005-08-01) -
Thrombosis and coagulopathy in COVID‐19: An illustrated review
by: Marcel Levi, et al.
Published: (2020-07-01) -
The subchronic effects of 3,4-methylendioxymethamphetamine on oxidative stress in rat brain
by: Simić Ivan, et al.
Published: (2014-01-01) -
Sepsis-Associated Coagulopathy
by: Scarlatescu Ecaterina, et al.
Published: (2016-10-01) -
Levetiracetam induced rhabdomyolysis
by: Anthony C. Torres, et al.
Published: (2021-01-01)